Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...
This advertisement has not loaded yet, but your article continues below. As was the fashion in the 1980s, Etobicoke’s Cloverdale Mall enclosed its open-air retail courtyard three decades after ...